← Evidence map

TrialWorld journal of clinical cases2024

Allogeneic mesenchymal stem cells may be a viable treatment modality in cerebral palsy.

Osman Boyalı et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38576742